Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, March 14 '26)

Image
By G.M.

 


    Antiviral Res

  1. ZHANG J, Deng S, Zhang M, Wu X, et al
    Porcine epidemic diarrhea virus infection activates SREBP2 and induces RORgamma expression to enhance cholesterol biosynthesis and virus replication.
    Antiviral Res. 2026 Mar 6:106391. doi: 10.1016/j.antiviral.2026.106391.
    PubMed         Abstract available


    Clin Infect Dis

  2. KHADER K, Haroldsen C, Stevens V, Visnovsky L, et al
    Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy.
    Clin Infect Dis. 2026 Mar 13:ciag176. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  3. LUGTU EJ, Iv DYP, Cabunoc MH, Bautista JL, et al
    Prevalence of Post-COVID Symptoms Across Variants of Concern and Follow-up Periods: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2026 Mar 10:108522. doi: 10.1016/j.ijid.2026.108522.
    PubMed         Abstract available

  4. TANG X, Memedi M, Sun S, Hiyoshi A, et al
    Machine learning-based 4-domain framework for evaluating COVID-19 policy responses: a counterfactual analysis of 27 European OECD countries.
    Int J Infect Dis. 2026 Mar 10:108528. doi: 10.1016/j.ijid.2026.108528.
    PubMed         Abstract available

  5. YONGHAO G, Yuting T, Huixin L, Minghua S, et al
    Characteristics of Respiratory Co-infections in Influenza-like Illness during the Post-COVID-19 Era.
    Int J Infect Dis. 2026 Mar 5:108507. doi: 10.1016/j.ijid.2026.108507.
    PubMed         Abstract available

  6. YANG M, Zhou M
    Re-evaluation of Treatment Strategies and Drug Development for Mycoplasma Pneumoniae.
    Int J Infect Dis. 2026 Feb 28:108510. doi: 10.1016/j.ijid.2026.108510.
    PubMed         Abstract available

  7. KATUMBA H, Migisha R, Komakech A, Wenani D, et al
    Delayed patient isolation and associated factors during the mpox outbreak in Uganda, July-December 2024.
    Int J Infect Dis. 2026;164:108346.
    PubMed         Abstract available


    J Infect

  8. ZHANG H, Kang Z, Zhang Y, Yang Y, et al
    Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence.
    J Infect. 2026 Mar 7:106718. doi: 10.1016/j.jinf.2026.106718.
    PubMed         Abstract available


    J Med Virol

  9. YOVEL G, Packard JE, Wang JC, Maya S, et al
    Neonatal CNS Human Parechovirus Infections in Western Pennsylvania in the 2024 Season.
    J Med Virol. 2026;98:e70870.
    PubMed         Abstract available

  10. CAO J, Yang G, Cui T, Qin J, et al
    Complement Hyperactivation Is Mediated by Alternative and Lectin Pathways During Early Phase of Severe Vaccination-Omicron BA.5 Infection.
    J Med Virol. 2026;98:e70863.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  11. MALONEY P, Reeves EL, Wielgosz K, Price AM, et al
    Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:116-123.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »